Leaflet COREYRA 5mg / 5mg capsules

Indicated for: hypertension

Route of administration: oral

Substance: ramipril + amlodipine (ACE inhibitor + calcium channel blocker)

ATC: C09BB07 (Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of ramipril and amlodipine is used for the treatment of high blood pressure and cardiovascular diseases. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor that helps relax blood vessels, while amlodipine is a calcium channel blocker that lowers blood pressure by relaxing the muscles of blood vessels.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and regularly monitor blood pressure.

Side effects may include dizziness, headache, swelling, or cough. In rare cases, severe adverse effects such as severe hypotension or allergic reactions may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney or liver impairment, to ensure the safe use of the ramipril and amlodipine combination.

General data about COREYRA 5mg / 5mg

  • Substance: ramipril + amlodipine
  • Date of latest medicines list: 01-10-2024
  • Product code: W64679001
  • Concentration: 5mg / 5mg
  • Pharmaceutical form: capsules
  • Quantity: 28
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: SWYSSI AG - GERMANIA
  • Holder: SWYSSI AG - GERMANIA
  • Number: 13951/2021/01
  • Shelf life: 3 years

Concentrations available for ramipril + amlodipine

  • 10mg/10mg
  • 10mg/5mg
  • 2.5mg/2.5mg
  • 2.5mg/5mg
  • 5mg/10mg
  • 5mg/5mg